March 19, 2024

Penn panel on "Legal Models for Psychedelics: Ethical, Clinical, and Practical Implications"

As psychedelics become increasingly mainstream, a variety of legal models are developing in tandem, including decriminalization, legalization, and more medicalized approaches, ranging from psychedelic services and therapy provided by specific state-licensed outlets and providers to traditional FDA drug approval. What are the ethical, clinical, and practical implications of these legal models for emerging psychedelic businesses and those interested in using psychedelics? Which models should be preferred – and which should be avoided? In this panel, experts will describe the current legal landscape for psychedelics, how it is playing out in practice, and what shape it should take in the future.


Ismail Ali
Director, Policy & Advocacy
Multidisciplinary Association for Psychedelic Studies

I. Glenn Cohen
James A. Attwood and Leslie Williams Professor of Law and Deputy Dean, Harvard Law School
Faculty Director, Petrie-Flom Center for Health Law Policy, Biotechnology & Bioethics

Natalie Gukasyan
Assistant Professor of Psychiatry
Columbia University Irving Medical Center

Steven Levine
SVP Patient Access and Medical Affairs
COMPASS Pathways

Holly Fernandez Lynch L’06
Assistant Professor of Medical Ethics, University of Pennsylvania Perelman School of Medicine
CTIC Affiliated Faculty

You can view the recording here:

Loading tweets...